Alerus Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Alerus Financial's BMY Position: Q2 2026 in Review
Alerus Financial increased its Bristol-Myers Squibb (BMY) stake by 118% in Q2 2026, buying an estimated $1.33M and bringing the position to 42,984 shares worth $2.48M. The position accounts for 0.11% of the portfolio, ranked #107.
Alerus Financial first reported a position in BMY in Q4 2022 and has held it in 4 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Alerus Financial held 42,984 shares of Bristol-Myers Squibb worth $2.48M as of Q2 2026.
- Alerus Financial bought 23,224 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.33M.
- Bristol-Myers Squibb made up 0.11% of Alerus Financial's portfolio in Q2 2026, its #107 holding.
- Alerus Financial first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 4 quarters since.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Alerus Financial's 13F filing for Q2 2026, filed 14 Aug 2026.